Last Updated: September 24, 2026

Patent: 10,064,923

✉ Email this page to a colleague

Summary for Patent: 10,064,923

Title:	Therapeutic cancer vaccines derived from a novel dendritic cell line
Abstract:	The invention is in the field of medical sciences. It provides means and methods for the treatment of cancer. More in particular, it provides cells and cell lines that can be developed into fully functional dendritic cells. These cells endogenously express cancer-specific antigens, which makes them particularly suited for the treatment of different kinds of cancer. More in particular, the invention relates to a precursor cell line for dendritic cells called DC-One as deposited at the DSMZ under accession number DSMZ ACC3189 on Nov. 15, 2012.
Inventor(s):	Sandra van Wetering, Adriana Marie Kruisbeek
Assignee:	Mendus BV
Application Number:	US14/648,210
Patent Claims:	see list of patent claims

Details for Patent 10,064,923

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Emergent Product Development Gaithersburg, Inc.	ACAM2000	smallpox (vaccinia) vaccine, live	Suspension	125158	31-Aug-07	⤷ Start Trial	2033-12-10
Janssen Biotech, Inc.	SIMPONI ARIA	golimumab	Injection	125433	18-Jul-13	⤷ Start Trial	2033-12-10
Bluebird Bio Inc.	LYFGENIA	lovotibeglogene autotemcel	Suspension	125788	December 08, 2023	⤷ Start Trial	2033-12-10
Genetix Biotherapeutics Inc.	LYFGENIA	lovotibeglogene autotemcel	Suspension	125788	8-Dec-23	⤷ Start Trial	2033-12-10
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,064,923

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Canada	2892518	⤷ Start Trial
Denmark	2931878	⤷ Start Trial
European Patent Office	2743344	⤷ Start Trial
European Patent Office	2931878	⤷ Start Trial
Spain	2613132	⤷ Start Trial
Poland	2931878	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.